Inspiremd, Inc. Announces Resignation of Marvin Slosman as Sole Discretion
July 17, 2020 at 09:29 am EDT
Share
InspireMD, Inc. announced resignation of Marvin Slosman as sole discretion. In the event Mr. Slosman voluntarily resigns without good reason, the company may, in its sole discretion, shorten the notice period and determine the date of termination without any obligation to pay Mr. Slosman any additional compensation other than the accrued obligations and without triggering a termination of Mr. Slosman’s employment without cause. In the event the Slosman Employment Agreement expires, or the company terminate Mr. Slosman’s employment for cause or Mr. Slosman voluntarily resigns without good reason, the company shall have no further liability or obligation to Mr. Slosman under the Slosman Employment Agreement.
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.